Diana Lüftner, from the Humboldt University, Berlin, Germany speaks to us from the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain, discussing clinical trials from a clinician’s point of view. Prof. Lüftner explains their purpose and what clinicians look for in a trial, and tells us the importance of reducing drug interchangeability during a patient’s course of treatment.